Updated
Anixa BiosciencesANIX · Healthcare
$3.18+4.95%
Market cap$110M
IndustryBiotechnology

Anixa Biosciences (ANIX) Earnings

Anixa Biosciences's next earnings report is expected on Tuesday, January 12, 2027.

Summary

In the quarter ended July 2026, Anixa Biosciences had revenue of —, and diluted EPS of -0.08.

On September 9, 2026 it reported EPS of -0.08 against an estimate of -0.08 (matched).

Report dates

ReportDateTimeEPS estimateEPS reportedResult
NextTue Jan 12, 2027 — — — —
LastWed Sep 9, 2026 — -0.08 -0.08 In line

Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.

Also reporting the week of January 11

CompanyDateTime
JPMorgan Chase & Co JPM Thu Jan 14 Before open
UnitedHealth Group Incorporated UNH Tue Jan 12 —
Bank of America Corp BAC Fri Jan 15 Before open
Morgan Stanley MS Thu Jan 14 —
Wells Fargo & Company WFC Thu Jan 14 Before open
Citigroup Inc. C Thu Jan 14 Before open
BlackRock Inc BLK Thu Jan 14 —
Bank of New York Mellon Corp BNY Fri Jan 15 Before open

Quarterly results

The last 12 quarters from Anixa Biosciences's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.

Quarter endedRevenueGrowthEPS (diluted)GrowthOp. marginFiled
Jul 31, 2026— — -0.08 — — 2026-09-09
Apr 30, 2026— — -0.07 — — 2026-06-10
Jan 31, 2026— — -0.08 — — 2026-03-09
Oct 31, 2025— — — — — 2026-01-12
Jul 31, 2025— — -0.07 — — 2025-09-10
Apr 30, 2025— — -0.09 — — 2025-05-28
Jan 31, 2025— — -0.10 — — 2025-03-11
Oct 31, 2024— — — — — 2025-01-10
Jul 31, 2024— — -0.10 — — 2024-09-06
Apr 30, 2024— — -0.10 — — 2024-06-04
Jan 31, 2024— — -0.10 — — 2024-03-12
Oct 31, 2023$0 — — — — 2024-01-16

Questions about Anixa Biosciences

When does Anixa Biosciences report earnings?

Anixa Biosciences's next earnings report is expected on January 12, 2027.

Did Anixa Biosciences beat earnings estimates?

In its report on September 9, 2026, Anixa Biosciences matched the EPS estimate: -0.08 reported against -0.08 expected.

How did Anixa Biosciences do last quarter?

In the quarter ended July 2026, Anixa Biosciences had revenue of —, and diluted EPS of -0.08.

From Anixa Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.

Investingly

Better research starts here.

Every filing, chart and insider trade behind Anixa Biosciences and thousands of other companies, in one place. Free to start.